Aldose reductase inhibitor
Their target, aldose reductase, is an enzyme that is normally present in many other parts of the body, and catalyzes one of the steps in the sorbitol(polyol) pathway that is responsible for fructose formation from glucose. Aldose reductase activity increases as the glucose concentration rises in diabetes in those tissues that are not insulin sensitive, which include the lenses, peripheral nerves and glomerulus. Sorbitol does not diffuse through cell membranes easily and therefore accumulates, causing osmotic damage which leads to retinopathy and neuropathy.
Diabetic cataract formation follows an increase in sugars in the lens. The excess sugar within the lens is reduced by aldose reductase to its alcohol, but the lens capsule is relatively impermeable to sugar alcohols. Because of the excess sugar alcohol (polyol), the lens imbibes water, causing osmotic imbalance. Eventually, increased sodium and decreased potassium levels and decreased glutathione levels lead to cataract formation. Topical administration of aldose reductase inhibitors have been shown to prevent the cataract in rats.
Asthma and COPD
This class of drugs is also under investigation as a possible root pathology modulating treatment for asthma and COPD since it has been shown that they inhibit goblet cell metaplasia in the respiratory epithelium, thereby reducing the copious mucous secretion associated with these.
- Várkonyi T, Kempler P (February 2008). "Diabetic neuropathy: new strategies for treatment". Diabetes, Obesity & Metabolism. 10 (2): 99–108. doi:10.1111/j.1463-1326.2007.00741.x. PMID 17593238.
- Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB (2008). "Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications". Asia Pacific Journal of Clinical Nutrition. 17 (4): 558–65. PMID 19114390.
- Raj PS, Prathapan A, Sebastian J, Antony AK, Riya MP, Rani MR, Biju H, Priya S, Raghu KG (2014). "Parmotrema tinctorum exhibits antioxidant, antiglycation and inhibitory activities against aldose reductase and carbohydrate digestive enzymes: an in vitro study". Natural Product Research. 28 (18): 1480–4. doi:10.1080/14786419.2014.909420. PMID 24735436.
- Newell FW (1982). Ophthalmology: Principles and Concepts (Fifth ed.). London: The CV Mosby Company. p. 332.
- Yadav UC, Aguilera-Aguirre L, Ramana KV, Boldogh I, Srivastava SK (2010). "Aldose reductase inhibition prevents metaplasia of airway epithelial cells". Plos One. 5 (12): e14440. doi:10.1371/journal.pone.0014440. PMC . PMID 21203431.